2026年4月9日 上午9:14 UTC / 路透社
节点运行失败
2026年3月18日，美国佐治亚州亚特兰大，美国疾病控制与预防中心罗亚尔校区外的标识牌。路透社/梅根·瓦纳 授权许可使用
相关公司
莫德纳公司 关注
诺瓦瓦克斯公司 关注
辉瑞公司 关注
4月9日（路透社）——据《华盛顿邮报》周四报道，美国疾病控制与预防中心代理主任推迟了一份CDC报告的发布，该报告显示，去年冬季新冠疫苗将健康成年人的急诊就诊和住院可能性降低了约一半。该报援引了解该决定的科学家的话称。
路透社无法立即核实这篇报道。美国卫生与公众服务部未立即回复置评请求。
通过路透社健康周刊专栏，及时了解最新医学突破和医疗保健趋势。点击此处订阅
本报记者：班加罗尔的迪沙·米什拉；编辑：亚历克斯·理查森
我们的报道准则：汤森路透信托原则。
US CDC delays publishing report showing COVID vaccine benefits, WaPo reports
April 9, 2026 9:14 AM UTC / Reuters
节点运行失败
A sign sits outside of the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia, U.S. March 18, 2026. REUTERS/Megan Varner Purchase Licensing Rights
Companies
Moderna Inc Follow
Novavax Inc Follow
Pfizer Inc Follow
April 9 (Reuters) – The acting director of the Centers for Disease Control and Prevention has delayed publication of a CDC report showing the COVID-19 vaccine cut the likelihood of emergency department visits and hospitalizations for healthy adults last winter by about half, the Washington Post reported on Thursday, citing scientists familiar with the decision.
Reuters could not immediately verify the report. Department of Health and Human Services did not immediately respond to request for comment.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Reporting by Disha Mishra in Bengaluru; Editing by Alex Richardson
Our Standards: The Thomson Reuters Trust Principles.
发表回复